Translational and HIF-1α-Dependent Metabolic Reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides

Laura Hulea, Simon Pierre Gravel, Masahiro Morita, Marie Cargnello, Oro Uchenunu, Young Kyuen Im, Camille Lehuédé, Eric H. Ma, Matthew Leibovitch, Shannon McLaughlan, Marie José Blouin, Maxime Parisotto, Vasilios Papavasiliou, Cynthia Lavoie, Ola Larsson, Michael Ohh, Tiago Ferreira, Celia Greenwood, Gaëlle Bridon, Daina Avizonis & 8 others Gerardo Ferbeyre, Peter Siegel, Russell G. Jones, William Muller, Josie Ursini-Siegel, Julie St-Pierre, Michael Pollak, Ivan Topisirovic

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

There is increasing interest in therapeutically exploiting metabolic differences between normal and cancer cells. We show that kinase inhibitors (KIs) and biguanides synergistically and selectively target a variety of cancer cells. Synthesis of non-essential amino acids (NEAAs) aspartate, asparagine, and serine, as well as glutamine metabolism, are major determinants of the efficacy of KI/biguanide combinations. The mTORC1/4E-BP axis regulates aspartate, asparagine, and serine synthesis by modulating mRNA translation, while ablation of 4E-BP1/2 substantially decreases sensitivity of breast cancer and melanoma cells to KI/biguanide combinations. Efficacy of the KI/biguanide combinations is also determined by HIF-1α-dependent perturbations in glutamine metabolism, which were observed in VHL-deficient renal cancer cells. This suggests that cancer cells display metabolic plasticity by engaging non-redundant adaptive mechanisms, which allows them to survive therapeutic insults that target cancer metabolism.

Original languageEnglish (US)
Pages (from-to)817-832.e8
JournalCell Metabolism
Volume28
Issue number6
DOIs
StatePublished - Dec 4 2018

Fingerprint

Biguanides
Phosphotransferases
Asparagine
Glutamine
Aspartic Acid
Serine
Neoplasms
Protein Biosynthesis
Renal Cell Carcinoma
Melanoma
Breast Neoplasms
Amino Acids

Keywords

  • biguanide
  • cancer
  • HIF-1α
  • kinase inhibitor
  • metabolic plasticity
  • metabolism
  • mRNA translation
  • mTORC1
  • non-essential amino acids

ASJC Scopus subject areas

  • Physiology
  • Molecular Biology
  • Cell Biology

Cite this

Translational and HIF-1α-Dependent Metabolic Reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides. / Hulea, Laura; Gravel, Simon Pierre; Morita, Masahiro; Cargnello, Marie; Uchenunu, Oro; Im, Young Kyuen; Lehuédé, Camille; Ma, Eric H.; Leibovitch, Matthew; McLaughlan, Shannon; Blouin, Marie José; Parisotto, Maxime; Papavasiliou, Vasilios; Lavoie, Cynthia; Larsson, Ola; Ohh, Michael; Ferreira, Tiago; Greenwood, Celia; Bridon, Gaëlle; Avizonis, Daina; Ferbeyre, Gerardo; Siegel, Peter; Jones, Russell G.; Muller, William; Ursini-Siegel, Josie; St-Pierre, Julie; Pollak, Michael; Topisirovic, Ivan.

In: Cell Metabolism, Vol. 28, No. 6, 04.12.2018, p. 817-832.e8.

Research output: Contribution to journalArticle

Hulea, L, Gravel, SP, Morita, M, Cargnello, M, Uchenunu, O, Im, YK, Lehuédé, C, Ma, EH, Leibovitch, M, McLaughlan, S, Blouin, MJ, Parisotto, M, Papavasiliou, V, Lavoie, C, Larsson, O, Ohh, M, Ferreira, T, Greenwood, C, Bridon, G, Avizonis, D, Ferbeyre, G, Siegel, P, Jones, RG, Muller, W, Ursini-Siegel, J, St-Pierre, J, Pollak, M & Topisirovic, I 2018, 'Translational and HIF-1α-Dependent Metabolic Reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides', Cell Metabolism, vol. 28, no. 6, pp. 817-832.e8. https://doi.org/10.1016/j.cmet.2018.09.001
Hulea, Laura ; Gravel, Simon Pierre ; Morita, Masahiro ; Cargnello, Marie ; Uchenunu, Oro ; Im, Young Kyuen ; Lehuédé, Camille ; Ma, Eric H. ; Leibovitch, Matthew ; McLaughlan, Shannon ; Blouin, Marie José ; Parisotto, Maxime ; Papavasiliou, Vasilios ; Lavoie, Cynthia ; Larsson, Ola ; Ohh, Michael ; Ferreira, Tiago ; Greenwood, Celia ; Bridon, Gaëlle ; Avizonis, Daina ; Ferbeyre, Gerardo ; Siegel, Peter ; Jones, Russell G. ; Muller, William ; Ursini-Siegel, Josie ; St-Pierre, Julie ; Pollak, Michael ; Topisirovic, Ivan. / Translational and HIF-1α-Dependent Metabolic Reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides. In: Cell Metabolism. 2018 ; Vol. 28, No. 6. pp. 817-832.e8.
@article{fae811fef4824e9cb6f336da6ce5d2b1,
title = "Translational and HIF-1α-Dependent Metabolic Reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides",
abstract = "There is increasing interest in therapeutically exploiting metabolic differences between normal and cancer cells. We show that kinase inhibitors (KIs) and biguanides synergistically and selectively target a variety of cancer cells. Synthesis of non-essential amino acids (NEAAs) aspartate, asparagine, and serine, as well as glutamine metabolism, are major determinants of the efficacy of KI/biguanide combinations. The mTORC1/4E-BP axis regulates aspartate, asparagine, and serine synthesis by modulating mRNA translation, while ablation of 4E-BP1/2 substantially decreases sensitivity of breast cancer and melanoma cells to KI/biguanide combinations. Efficacy of the KI/biguanide combinations is also determined by HIF-1α-dependent perturbations in glutamine metabolism, which were observed in VHL-deficient renal cancer cells. This suggests that cancer cells display metabolic plasticity by engaging non-redundant adaptive mechanisms, which allows them to survive therapeutic insults that target cancer metabolism.",
keywords = "biguanide, cancer, HIF-1α, kinase inhibitor, metabolic plasticity, metabolism, mRNA translation, mTORC1, non-essential amino acids",
author = "Laura Hulea and Gravel, {Simon Pierre} and Masahiro Morita and Marie Cargnello and Oro Uchenunu and Im, {Young Kyuen} and Camille Lehu{\'e}d{\'e} and Ma, {Eric H.} and Matthew Leibovitch and Shannon McLaughlan and Blouin, {Marie Jos{\'e}} and Maxime Parisotto and Vasilios Papavasiliou and Cynthia Lavoie and Ola Larsson and Michael Ohh and Tiago Ferreira and Celia Greenwood and Ga{\"e}lle Bridon and Daina Avizonis and Gerardo Ferbeyre and Peter Siegel and Jones, {Russell G.} and William Muller and Josie Ursini-Siegel and Julie St-Pierre and Michael Pollak and Ivan Topisirovic",
year = "2018",
month = "12",
day = "4",
doi = "10.1016/j.cmet.2018.09.001",
language = "English (US)",
volume = "28",
pages = "817--832.e8",
journal = "Cell Metabolism",
issn = "1550-4131",
publisher = "Cell Press",
number = "6",

}

TY - JOUR

T1 - Translational and HIF-1α-Dependent Metabolic Reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides

AU - Hulea, Laura

AU - Gravel, Simon Pierre

AU - Morita, Masahiro

AU - Cargnello, Marie

AU - Uchenunu, Oro

AU - Im, Young Kyuen

AU - Lehuédé, Camille

AU - Ma, Eric H.

AU - Leibovitch, Matthew

AU - McLaughlan, Shannon

AU - Blouin, Marie José

AU - Parisotto, Maxime

AU - Papavasiliou, Vasilios

AU - Lavoie, Cynthia

AU - Larsson, Ola

AU - Ohh, Michael

AU - Ferreira, Tiago

AU - Greenwood, Celia

AU - Bridon, Gaëlle

AU - Avizonis, Daina

AU - Ferbeyre, Gerardo

AU - Siegel, Peter

AU - Jones, Russell G.

AU - Muller, William

AU - Ursini-Siegel, Josie

AU - St-Pierre, Julie

AU - Pollak, Michael

AU - Topisirovic, Ivan

PY - 2018/12/4

Y1 - 2018/12/4

N2 - There is increasing interest in therapeutically exploiting metabolic differences between normal and cancer cells. We show that kinase inhibitors (KIs) and biguanides synergistically and selectively target a variety of cancer cells. Synthesis of non-essential amino acids (NEAAs) aspartate, asparagine, and serine, as well as glutamine metabolism, are major determinants of the efficacy of KI/biguanide combinations. The mTORC1/4E-BP axis regulates aspartate, asparagine, and serine synthesis by modulating mRNA translation, while ablation of 4E-BP1/2 substantially decreases sensitivity of breast cancer and melanoma cells to KI/biguanide combinations. Efficacy of the KI/biguanide combinations is also determined by HIF-1α-dependent perturbations in glutamine metabolism, which were observed in VHL-deficient renal cancer cells. This suggests that cancer cells display metabolic plasticity by engaging non-redundant adaptive mechanisms, which allows them to survive therapeutic insults that target cancer metabolism.

AB - There is increasing interest in therapeutically exploiting metabolic differences between normal and cancer cells. We show that kinase inhibitors (KIs) and biguanides synergistically and selectively target a variety of cancer cells. Synthesis of non-essential amino acids (NEAAs) aspartate, asparagine, and serine, as well as glutamine metabolism, are major determinants of the efficacy of KI/biguanide combinations. The mTORC1/4E-BP axis regulates aspartate, asparagine, and serine synthesis by modulating mRNA translation, while ablation of 4E-BP1/2 substantially decreases sensitivity of breast cancer and melanoma cells to KI/biguanide combinations. Efficacy of the KI/biguanide combinations is also determined by HIF-1α-dependent perturbations in glutamine metabolism, which were observed in VHL-deficient renal cancer cells. This suggests that cancer cells display metabolic plasticity by engaging non-redundant adaptive mechanisms, which allows them to survive therapeutic insults that target cancer metabolism.

KW - biguanide

KW - cancer

KW - HIF-1α

KW - kinase inhibitor

KW - metabolic plasticity

KW - metabolism

KW - mRNA translation

KW - mTORC1

KW - non-essential amino acids

UR - http://www.scopus.com/inward/record.url?scp=85059307650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059307650&partnerID=8YFLogxK

U2 - 10.1016/j.cmet.2018.09.001

DO - 10.1016/j.cmet.2018.09.001

M3 - Article

VL - 28

SP - 817-832.e8

JO - Cell Metabolism

JF - Cell Metabolism

SN - 1550-4131

IS - 6

ER -